{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:07:14Z","timestamp":1770998834897,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":692,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:sec><jats:title>Bakcground<\/jats:title><jats:p>: In Asian countries with limited resources, clarithromycin\u2010based triple therapy may not be readily available. There are also few direct comparisons of different regimens in Asia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>: To compare two lansoprazole\u2010based non\u2010clarithromycin triple therapies and one dual therapy in a prospective double\u2010blind placebo\u2010controlled study of <jats:italic>Helicobacter pylori<\/jats:italic> eradication and duodenal ulcer healing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>: Fourteen centres in Asia participated in this study. Patients with acute duodenal ulcer who were <jats:italic>H. pylori<\/jats:italic>\u2010positive were recruited. They were randomized to receive: (a) lansoprazole 30\u2003mg b.d., amoxycillin 1\u2003g b.d. and metronidazole 500\u2003mg b.d. for 2\u2003weeks (LAM\u20102\u2003W), or (b) LAM for 1\u2003week and placebo (LAM\u20101\u2003W), or (c) lansoprazole 30\u2003mg b.d., amoxycillin 1\u2003g b.d. and placebo for 2\u2003weeks (LA\u20102\u2003W). Upper endoscopy was repeated at week 6 to check for duodenal ulcer healing. Symptoms and side\u2010effects were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>: A total of 228 patients were recruited, and two patients took less than 50% of the drugs. <jats:italic>H. pylori<\/jats:italic> eradication rates (intention\u2010to\u2010treat) were 68 out of 82 (83%) with LAM\u20102\u2003W, 55 out of 71 (78%) with LAM\u20101\u2003W and 43 out of 75 (57%) with LA\u20102\u2003W. There were significant differences (<jats:italic>P<\/jats:italic>=0.001) in eradication rates when comparing either LAM\u20102\u2003W or LAM\u20101\u2003W with LA\u20102\u2003W. The eradication rate in patients with metronidazole resistant <jats:italic>H. pylori<\/jats:italic> strains were significantly lower than those with metronidazole sensitive strains (<jats:italic>P<\/jats:italic>=0.0001). The duodenal ulcer healing rates at week 6 were 85%, 85% and 72% in LAM\u20102\u2003W, LAM\u20101\u2003W and LA\u20102\u2003W, respectively (<jats:italic>P<\/jats:italic>=0.065). Side\u2010effects occurred in 13%, 11% and 9% in LAM\u20102\u2003W, LAM\u20101\u2003W and LA\u20102\u2003W, respectively. <jats:italic>H. pylori<\/jats:italic> eradication and initial ulcer size were factors affecting duodenal ulcer healing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>: This Asian multicentre study showed that 1\u2010week lansoprazole\u2010based triple therapy without clarithromycin has similar efficacy in <jats:italic>H. pylori<\/jats:italic> eradication and ulcer healing compared with a 2\u2010week regimen. Both triple therapies were significantly better than dual therapy in <jats:italic>H. pylori<\/jats:italic> eradication. Therefore, 1\u2010week lansoprazole\u2010based triple therapy is as safe and effective as 2\u2010week therapy in eradication of <jats:italic>H. pylori<\/jats:italic> infection and healing of duodenal ulcer in these Asian centres.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00689.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:52Z","timestamp":1047354052000},"page":"217-224","source":"Crossref","is-referenced-by-count":55,"title":["Comparison of lansoprazole\u2010based triple and dual therapy for treatment of <i>Helicobacter pylori<\/i>\u2010related duodenal ulcer: an Asian multicentre double\u2010blind randomized placebo controlled study"],"prefix":"10.1111","volume":"14","author":[{"family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"DALDIYONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Manan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lesmana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Fock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kachintorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Phornphutkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kullavanijaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00537.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00477.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00248.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007509"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00458.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.675"},{"key":"e_1_2_6_8_2","first-page":"743","article-title":"H. pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens","volume":"86","author":"Bell GD","year":"1993","journal-title":"Q J Med"},{"key":"e_1_2_6_9_2","first-page":"248","article-title":"Highly effective twice\u2010daily triple therapies for H. pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?","volume":"92","author":"Lerang F","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.155329000.x"},{"key":"e_1_2_6_11_2","first-page":"A6","article-title":"Correlation between the MICS of metronidazole on H. pylori strains and the outcome of a lansoprazole\u2013amoxicillin\u2013metronidazole therapy","volume":"39","author":"Bouchard S","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.6.735"},{"key":"e_1_2_6_13_2","first-page":"A6","article-title":"Prevalence of metronidazole in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate H. pylori","volume":"39","author":"Moayyedi P","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2357"},{"key":"e_1_2_6_15_2","first-page":"A5","article-title":"High cure rate of H. pylori infection by one week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance","volume":"39","author":"Peitz U","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.100272000.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00046.x"},{"key":"e_1_2_6_18_2","first-page":"1415","article-title":"Variability with omeprazole\u2013amoxicillin combinations for treatment of Helicobacter pylori infection","volume":"90","author":"Graham KS","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_19_2","first-page":"1411","article-title":"Treatment of Helicobacter pylori infection with omeprazole\u2013amoxicllin combination therapy versus ranitidine\/sodium bicarbonate\u2010amoxicillin","volume":"90","author":"Al\u2010Assi MT","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_20_2","first-page":"170","article-title":"Effect of lansoprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori: a randomized, double blind, multicenter study","volume":"110","author":"Lamouliatte H","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.43"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-4-266"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.2.97"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098287"},{"key":"e_1_2_6_27_2","first-page":"1419","article-title":"Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1\u2010year follow\u2010up period: a prospective, randomized, controlled study","volume":"9","author":"Saberi\u2010Firoozi M","year":"1995","journal-title":"Am J Gastroenterol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00689.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00689.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00689.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:02:19Z","timestamp":1697439739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00689.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00689.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00689.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}